V-Wave
Rotem Hanania is an experienced Clinical Trial Manager at V-Wave since August 2019, following a role as a Clinical Research Associate (CRA) at LifeBond Ltd. from September 2017 to August 2019. Prior to that, Rotem worked as a Clinical Research Associate at Neuronix Medical from September 2015 to September 2017 and as a Research Assistant at The Hebrew University of Jerusalem from February 2014 to September 2015. Rotem holds a Master of Business Administration (MBA) from Tel Aviv University (2016-2018), a course in Clinical Research Associate and Good Clinical Practice from Bioforum (2015), and a Bachelor's Degree in Biology from The Hebrew University of Jerusalem (2012-2015).
V-Wave
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.